BillionToOne, Inc. Class A Common Stock (BLLN) - Total Liabilities
Based on the latest financial reports, BillionToOne, Inc. Class A Common Stock (BLLN) has total liabilities worth $195.11 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is BillionToOne, Inc. Class A Common Stock growing its equity to track the company's year-over-year net asset growth rate.
BillionToOne, Inc. Class A Common Stock - Total Liabilities Trend (2023–2025)
This chart illustrates how BillionToOne, Inc. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data. See BLLN cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
BillionToOne, Inc. Class A Common Stock Competitors by Total Liabilities
The table below lists competitors of BillionToOne, Inc. Class A Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Adaro Minerals Indonesia Tbk PT
JK:ADMR
|
Indonesia | Rp891.42 Million |
|
Motor Oil (Hellas) Corinth Refineries S.A
AT:MOH
|
Greece | €4.68 Billion |
|
Skyline Corporation
NYSE:SKY
|
USA | $522.09 Million |
|
M/I Homes Inc
NYSE:MHO
|
USA | $1.64 Billion |
|
Hangzhou Binjiang Real Estate Group Co Ltd
SHE:002244
|
China | CN¥151.18 Billion |
|
Galaxy Digital Holdings Ltd
NASDAQ:GLXY
|
USA | $7.21 Billion |
|
Acerinox
MC:ACX
|
Spain | €3.60 Billion |
|
Indorama Ventures PCL
BK:IVL
|
Thailand | ฿394.53 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down BillionToOne, Inc. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BillionToOne, Inc. Class A Common Stock (BLLN) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BillionToOne, Inc. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BillionToOne, Inc. Class A Common Stock (2023–2025)
The table below shows the annual total liabilities of BillionToOne, Inc. Class A Common Stock from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $152.55 Million | +13.58% |
| 2024-12-31 | $134.31 Million | -16.69% |
| 2023-12-31 | $161.20 Million | -- |
About BillionToOne, Inc. Class A Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, an… Read more